NEXGEL, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
NEXGEL, INC. (NXGL) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $2.29 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-17
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.29M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $37.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $30.00K.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $62.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $2.29M 10-Q · filed 2026-08-17 |
| 2026-03-31 | $37.00K 10-Q · filed 2026-05-14 |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $62.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $93.00K 10-Q · filed 2025-05-13 |
| 2024-09-30 | $32.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $48.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $95.00K 10-Q · filed 2024-05-13 |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.00K 10-Q · filed 2023-05-15 |
| 2022-09-30 | $4.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $11.00K 10-Q · filed 2022-05-13 |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $7.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $11.00K 10-Q · filed 2021-05-17 |
| 2020-09-30 | $29.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |